Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review
The Pharma Data
DECEMBER 13, 2020
Since its establishment, Viva Biotech has been providing comprehensive new drug R&D services to nearly 500 world’s top pharmaceutical and biotech companies based on Viva’s excellence in structure-based drug discovery. Dr. Xueheng Cheng, CTO of Viva Biotech, introduced the ASMS technology platform.
Let's personalize your content